Non-specific bacterial and mucosal proteins

Non-specific bacterial and mucosal proteins refers to a broad group of proteins that serve as the therapeutic targets for certain gastrointestinal medications, primarily bismuth-containing compounds and sucralfate (DrugBank DB01294, DB00364). These agents do not target a single specific receptor or enzyme; instead, they interact with a wide variety of proteins in both bacterial pathogens and the human host's gastric environment (StatPearls, NBK537071). In bacteria, such as Helicobacter pylori, the binding to structural and functional proteins leads to the disruption of the cell wall and inhibition of essential metabolic pathways, resulting in antimicrobial effects (PubChem CID 16682734). In the human gastrointestinal tract, these drugs bind to proteins like albumin and fibrinogen that are exposed at the site of mucosal injury or peptic ulcers. This binding creates a protective physical barrier or coating that shields the underlying tissue from the damaging effects of gastric acid, pepsin, and bile, thereby promoting the healing of the mucosa (Journal of Gastroenterology, 1991). Due to the heterogeneous nature of the proteins involved, this target is characterized by its non-specific binding mechanism.

Other names

Bacterial proteinsMucosal proteinsGastrointestinal mucosal proteinsBismuth-binding proteins

Bismuth compounds and sucralfate bind non-specifically to bacterial proteins to disrupt cell walls and to mucosal proteins at ulcer sites to form a protective physical barrier.